Hodgkin's lymphoma

Results: 6



#Item
1Why we focus on Lymphoma There are two main types of lymphoma, Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL). Both are cancers of the lymphatic system and usually present as swelling of the lymph nodes. Al

Why we focus on Lymphoma There are two main types of lymphoma, Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL). Both are cancers of the lymphatic system and usually present as swelling of the lymph nodes. Al

Add to Reading List

Source URL: www.bci.qmul.ac.uk

- Date: 2016-04-04 11:36:10
    2KIT FOR MOLECULAR STUDY OF TRANSLOCATION t(11;14) Nº CAT. MAD-003998MDETERMINATIONS) Mantle cell lymphomas are a sub-type of non-Hodgkin’s lymphoma derived from a subset of virgin B-cells localised in the man

    KIT FOR MOLECULAR STUDY OF TRANSLOCATION t(11;14) Nº CAT. MAD-003998MDETERMINATIONS) Mantle cell lymphomas are a sub-type of non-Hodgkin’s lymphoma derived from a subset of virgin B-cells localised in the man

    Add to Reading List

    Source URL: www.masterdiagnostica.com

    Language: English - Date: 2014-11-06 04:24:19
    3The recent approval of 90Y-labeled Zevalin (IDEC Pharmaceuticals Corp., San Diego, CA) for radioimmunotherapy of non-Hodgkin’s lymphoma has highlighted the regulatory requirement of patient-specific internal radiati

    The recent approval of 90Y-labeled Zevalin (IDEC Pharmaceuticals Corp., San Diego, CA) for radioimmunotherapy of non-Hodgkin’s lymphoma has highlighted the regulatory requirement of patient-specific internal radiati

    Add to Reading List

    Source URL: www.aapm.org

    Language: English - Date: 2005-10-18 14:16:03
    4SEER Cancer Statistics Review[removed]Table 9.1 Hodgkin Lymphoma Trends in SEER Incidenceab and U.S. Mortalityc Using the Joinpoint Regression Program, [removed]With up to Five Joinpoints, [removed]With up to Three

    SEER Cancer Statistics Review[removed]Table 9.1 Hodgkin Lymphoma Trends in SEER Incidenceab and U.S. Mortalityc Using the Joinpoint Regression Program, [removed]With up to Five Joinpoints, [removed]With up to Three

    Add to Reading List

    Source URL: seer.cancer.gov

    Language: English - Date: 2014-12-16 11:15:02
    5Oncologic Drugs Advisory Committee Meeting Briefing Document Pixantrone dimaleate (BBR[removed]Injection for the treatment of patients with relapsed or refractory aggressive Non-Hodgkin’s Lymphoma who have received 2 or

    Oncologic Drugs Advisory Committee Meeting Briefing Document Pixantrone dimaleate (BBR[removed]Injection for the treatment of patients with relapsed or refractory aggressive Non-Hodgkin’s Lymphoma who have received 2 or

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    6NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Non-Hodgkin’s Lymphomas

    NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Non-Hodgkin’s Lymphomas

    Add to Reading List

    Source URL: cutaneouslymphoma.stanford.edu

    Language: English - Date: 2014-01-17 11:32:03